Linda Palczuk - Director, Avadel Pharmaceuticals Plc

As of May 31, 2022


What is Linda Palczuk's Net Worth?

The current estimated net worth of Avadel Pharmaceuticals Plc's Director, Linda Palczuk, is estimated to be about $114.93K . Linda Palczuk owns about 47,900 units of Avadel Pharmaceuticals Plc common stock. In the last 4 years at Avadel Pharmaceuticals Plc, Linda Palczuk has sold an estimated value of $0 worth.

What is Linda Palczuk's Past Insider Trading?

Linda Palczuk's largest purchase order was 7,500 units , worth over $44.33K on December 5, 2019. In total, Linda Palczuk has made about 7 transactions over 4 years of their time at Avadel Pharmaceuticals Plc. Linda Palczuk usually trades in August, with the busiest year in 2020 and 2019. The most recent transaction was a purchase order of 10,000 units , worth over $16K on May 31, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Linda Palczuk's' Mailing Address?

  • Mailing address is 7015 Albert Einstein Drive Columbia MD 21046 MD

Avadel Pharmaceuticals Plc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Gregory J. Divis 2020 $520,000 - $2,246,694 $3,143,694 $23,400 $3,143,694
Gregory J. Divis 2019 $472,292 $33,300 $485,010 $1,436,262 $23,316 $1,436,262
Gregory J. Divis 2018 $417,178 - $198,500 $685,428 $23,000 $685,428
Thomas S. McHugh 2020 $385,000 - $898,678 $1,479,878 $11,400 $1,479,878
Thomas S. McHugh 2019 $33,688 - $469,600 $503,288 - $503,288
Jordan S. Dubow 2020 $368,756 - $254,604 $859,740 $236,381 $859,740
Jordan S. Dubow 2019 $293,296 - $273,258 $743,224 $10,282 $743,224
Phillandas T. Thompson 2020 $310,594 - - $850,652 $417,041 $850,652
Phillandas T. Thompson 2019 $383,400 $33,300 $103,250 $698,157 $21,780 $698,157
Phillandas T. Thompson 2018 $365,968 - - $450,378 $20,000 $450,378
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1012477/000110465921059020/tm212548-2_def14a.htm

What are Avadel Pharmaceuticals Plc's Past Insider Trades?

Avadel Pharmaceuticals Plc's most recent insider trade came on June 2, 2022 by Michael Geoffrey Glass who bought 45,000 units worth $96.3K . In the last 5 years, insiders at Avadel Pharmaceuticals Plc have sold an estimated value of $6.27M and bought an estimated value of $5.11M worth of shares. Insider trading is most common in January, with the busiest year in 2017. The most active traders at the company are Craig R Stapleton, Director,  Eric Ende, Director,  and Gregory Divis, Chief Executive Officer .

AVADEL PHARMACEUTICALS PLC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1